Novo Nordisk A/S et al. v. Biocon Pharma, Ltd. et al.
Infringement action filed 14 Jul 2022 in the United States District Court for the District of Delaware and closed 20 Dec 2023, with 3 patents asserted. Recorded basis of termination: dismissed without prejudice.
Case record
- Patents involved
- US9265893B2US7762994B2US8114833B2
- Case no.
- 1:22-cv-00936
- Verdict cause
- Infringement action
- Court
- D. Del.
- Court level
- District Court
- Case region
- Delaware
- Chief judge
- Colm F. Connolly
- Trial level
- First instance
- Filed – Closed
- 14 Jul 2022 – 20 Dec 2023
- Duration
- 524 days
- Basis of termination
- Dismissed without Prejudice
- Products & marks
- Victoza® Liraglutide Recombinant Solution Injection, 18 mg/3 ml (6 mg/ml)
Check this patent against your own product
Prior art, claim scope, infringement exposure and design-around routes. Every answer cites the records behind it.
Get an FTO claim chart- 01Ranked prior artEvery hit source-linked
- 02Claim-level comparisonAgainst your own product
- 03Legal statusAcross 174 jurisdictions
Injection button
A push button connection for an injection device comprising a push button (10) and a driving part (20). The two parts of the push button connection are mounted to each other and is relatively rotatable to each other. In order to minimize the friction occurring between the push button and the driving part when relatively rotated forces are transmitted via a pivot bearing (18, 22). In order also to minimize the effect of forces appearing dislocated from the center line a number of radial bearings (13, 23; 14, 25) having a little friction diameter is provided.
- Legal status
- Active
- Granted
- 23 Feb 2016
- Earliest priority
- 5 Feb 2007
- Est. expiry
- 23 Mar 2033
- Validity challenges
- None recorded
- Licences recorded
- None recorded
- Inventors
- HANSEN, TORBEN STROEM · WIELANDT, JAKOB OEST · GROTH, LARS MOERCH
- Classification
- A61M5/00A61M5/315
- Prosecution counsel
- NOVO NORDISK INC.
- Examiner
- GRAY, PHILLIP
Needle mounting system and a method for mounting a needle assembly
A needle mounting system and methods for mounting a needle assembly on a needle mount are disclosed. The needle mounting system includes a needle hub having protrusions extending radially inward. A needle mount has a plurality of slots to receive the protrusions. The slots have a first portion that defines a passageway substantially parallel to a longitudinal axis of the needle mount and a second portion substantially perpendicular to the axis. The needle hub and mount provide a method wherein a needle assembly may be mounted on an injection device without completely rotating the needle hub relative to the needle mount.
- Legal status
- Inactive
- Granted
- 27 Jul 2010
- Earliest priority
- 1 Aug 2002
- Est. expiry
- 23 Nov 2024
- Validity challenges
- None recorded
- Licences recorded
- None recorded
- Inventors
- KLINT, HENRIK SONDERSKOV · RADMER, JIM · SMEDEGAARD, JORGEN K · NIELSEN, JAN FRANK · JENSEN, PETER MOLLER · JENSEN, JENS MOLLER
- Classification
- A61M5/00A61M5/34
- Prosecution counsel
- NOVO NORDISK INC.
- Examiner
- SIRMONS, KEVIN C
Also asserted in this case
1 moreThe docket lists 3 asserted patents. Full bibliographic detail, drawings and prosecution history for the remaining asserted patent are one query away in Eureka.
Parties of record
Novo Nordisk A/S
- Core tech
- A61M5/00A61M5/315A61M5/34
- Counsel
- Brian P. Egan · Jack B. Blumenfeld · Travis J. Murray
- Firm
- Morris, Nichols, Arsht & Tunnell LLP
- Also named
- Novo Nordisk A/S
Biocon Pharma, Ltd.
- Core tech
- Not recorded
- Counsel
- Christopher W. West · Cortlan S. Hitch · Deepro R. Mukerjee · Jitendra M. Malik · Kenneth Laurence Dorsney · Lance A. Soderstrom · Matthew M. Holub · Rachel J. Schaub
- Firm
- Morris James LLP
- Also named
- Biocon Pharma, Inc. · Biocon, Ltd.
Counsel of record
| Attorney | For | Role |
|---|---|---|
| Brian P. Egan | Novo Nordisk A/S | Plaintiff |
| Jack B. Blumenfeld | Novo Nordisk A/S | Plaintiff |
| Travis J. Murray | Novo Nordisk A/S | Plaintiff |
| Christopher W. West | Biocon Pharma, Ltd. | Defendant |
| Cortlan S. Hitch | Biocon Pharma, Ltd. | Defendant |
| Deepro R. Mukerjee | Biocon Pharma, Ltd. | Defendant |
| Jitendra M. Malik | Biocon Pharma, Ltd. | Defendant |
| Kenneth Laurence Dorsney | Biocon Pharma, Ltd. | Defendant |
| Lance A. Soderstrom | Biocon Pharma, Ltd. | Defendant |
| Matthew M. Holub | Biocon Pharma, Ltd. | Defendant |
| Rachel J. Schaub | Biocon Pharma, Ltd. | Defendant |
Basis of termination
From the record · verbatim“STIPULATION AND ORDER OF DISMISSAL of Case No. 22-936”
Case 1:22-cv-00936 · D. Del. · closed 20 December 2023
Related cases
Three questions this record usually leads to. Each one runs against the full litigation and patent corpus, and cites what it finds.
Frequently asked questions
What is case 1:22-cv-00936?
1:22-cv-00936 is a patent infringement action brought by Novo Nordisk A/S against Biocon Pharma, Ltd., filed on 14 Jul 2022 in the United States District Court for the District of Delaware. The case closed on 20 December 2023.
Which patents were asserted in 1:22-cv-00936?
US9265893B2 (“Injection button”), assigned to NOVO NORDISK A/S, currently active; US7762994B2 (“Needle mounting system and a method for mounting a needle assembly”), assigned to NOVO NORDISK A/S, currently inactive; US8114833B2 (“Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices”), assigned to NOVO NORDISK A/S. The record also lists Victoza® Liraglutide Recombinant Solution Injection, 18 mg/3 ml (6 mg/ml).
How was case 1:22-cv-00936 terminated?
The recorded basis of termination is dismissed without prejudice. The termination text reads: “STIPULATION AND ORDER OF DISMISSAL of Case No. 22-936”
What does dismissal without prejudice mean?
A dismissal without prejudice ends this action but leaves the claims alive — the plaintiff may file them again later, subject to the limitation period.
How long did case 1:22-cv-00936 take?
524 calendar days, from filing on 14 Jul 2022 to closure on 20 December 2023.
Who were the attorneys and the judge in 1:22-cv-00936?
Chief Judge Colm F. Connolly presided. Brian P. Egan, Jack B. Blumenfeld and Travis J. Murray are recorded as counsel for plaintiff Novo Nordisk A/S. Christopher W. West, Cortlan S. Hitch, Deepro R. Mukerjee, Jitendra M. Malik, Kenneth Laurence Dorsney, Lance A. Soderstrom, Matthew M. Holub and Rachel J. Schaub appear for defendant Biocon Pharma.
Disclaimer. This page reproduces publicly available court docket data for case 1:22-cv-00936 and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Docket data has limits. Records are drawn from a snapshot and may lag the live docket. Sealed filings, amended complaints, counterclaims and post-closure motions may not be reflected. Party names, attorney names and firm affiliations are reproduced as recorded and may contain omissions. Where a field is absent from the record, this page marks it as not recorded rather than inferring a value.
No characterisation of the parties or the outcome. This page reports what the record contains. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, that any settlement occurred, or that any party prevailed.
No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.